Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
Authors:
- Tannia GutierrezTGTannia Gutierrez
- Darren FegleyDFDarren Fegley
- Daniele PiomelliDPDaniele Piomelli
- Andrea G. HohmannAHAndrea G. Hohmann
Open Access
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 50 (3) , 372-379
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channelsLife Sciences, 2005
- Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid systemCurrent Opinion in Chemical Biology, 2003
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProceedings of the National Academy of Sciences, 2001
- The Vanilloid Receptor: A Molecular Gateway to the Pain PathwayAnnual Review of Neuroscience, 2001
- The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the ratBritish Journal of Pharmacology, 1999
- Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide HydrolaseBiochemical and Biophysical Research Communications, 1998
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in LeukocytesJournal of Biological Chemistry, 1997
- Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesNature, 1996
- The Many Possible Roles of Opioids and Related Peptides in Stress‐Induced AnalgesiaaAnnals of the New York Academy of Sciences, 1986